PTC Therapeutics Ownership 2024 | Who Owns PTC Therapeutics Now?
Institutional Ownership
12.75%
Insider Ownership
2.35%
Retail Ownership
84.91%
Institutional Holders
71.00
PTC Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11.73% | 0.01% | 8,973,771 | -395,243 | -4.22% | 274,417,917 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 10.73% | 0.04% | 8,208,606 | -692,959 | -7.78% | 251,019,171 | Jun 30, 2024 |
| BLACKROCK INC. | 10.16% | 0.01% | 7,772,140 | 207,054 | 2.74% | 237,672,042 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.66% | 3.50% | 7,393,127 | -30,843 | -0.42% | 226,081,824 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.10% | 2.68% | 6,962,227 | 198,227 | 2.93% | 212,904,902 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.91% | 3.16% | 3,756,469 | 30,843 | 0.83% | 114,872,822 | Jun 30, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 4.58% | 2.96% | 3,500,000 | -500,000 | -12.50% | 107,030,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.90% | 0.05% | 2,981,559 | -688,257 | -18.75% | 91,147,762 | Jun 30, 2024 |
| STATE STREET CORP | 3.59% | 0.00% | 2,749,340 | -1,360,452 | -33.10% | 84,074,817,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.34% | 0.00% | 1,787,780 | 124,712 | 7.50% | 54,681,341 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.24% | 0.22% | 1,715,791 | 109,950 | 6.85% | 52,468,889 | Jun 30, 2024 |
| MORGAN STANLEY | 1.98% | 0.00% | 1,516,757 | -546,284 | -26.48% | 46,382,445 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.92% | 0.01% | 1,470,350 | -11,138 | -0.75% | 44,963,303 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.77% | 0.04% | 1,357,638 | 131,890 | 10.76% | 41,516,570 | Jun 30, 2024 |
| FMR LLC | 1.44% | 0.00% | 1,104,099 | -622,963 | -36.07% | 33,763,347 | Jun 30, 2024 |
| BLACKSTONE INC. | 1.43% | 0.14% | 1,095,290 | - | - | 33,493,968 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.07% | 0.04% | 818,100 | 56,700 | 7.45% | 25,017,498 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.03% | 0.00% | 791,164 | 311,143 | 64.82% | 24,193,795 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.02% | 0.09% | 783,062 | 23,681 | 3.12% | 23,946,036 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.92% | 2.18% | 700,000 | - | - | 21,406,000 | Jun 30, 2024 |
PTC Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 11.73% of the company's total share outstanding, currently valued at $274.42M. The top 10 institutional shareholders own together 70.70% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.66% | 3.50% | 7,393,127 | -30,843 | -0.42% | 226,081,824 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.91% | 3.16% | 3,756,469 | 30,843 | 0.83% | 114,872,822 | Jun 30, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 4.58% | 2.96% | 3,500,000 | -500,000 | -12.50% | 107,030,000 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.10% | 2.68% | 6,962,227 | 198,227 | 2.93% | 212,904,902 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.92% | 2.18% | 700,000 | - | - | 21,406,000 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.18% | 0.40% | 139,380 | -35,859 | -20.46% | 4,262,240 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.12% | 0.39% | 94,318 | 94,318 | 100.00% | 2,884,244 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.02% | 0.26% | 15,930 | -28,564 | -64.20% | 487,139 | Jun 30, 2024 |
| NEO IVY CAPITAL MANAGEMENT | 0.05% | 0.24% | 40,708 | 40,708 | 100.00% | 1,245,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.24% | 0.22% | 1,715,791 | 109,950 | 6.85% | 52,468,889 | Jun 30, 2024 |
| VITALSTONE FINANCIAL, LLC | 0.01% | 0.21% | 9,367 | 9,367 | 100.00% | 286,443 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.12% | 0.21% | 90,000 | 90,000 | 100.00% | 2,752,200 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.02% | 0.18% | 19,000 | 19,000 | 100.00% | 581,020 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.18% | 4,055 | 1,794 | 79.35% | 124,002 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.68% | 0.17% | 522,895 | 250,000 | 91.61% | 15,990,129 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.04% | 0.16% | 27,997 | 27,997 | 100.00% | 856,148 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.08% | 0.15% | 57,812 | 57,812 | 100.00% | 1,767,891 | Jun 30, 2024 |
| BLACKSTONE INC. | 1.43% | 0.14% | 1,095,290 | - | - | 33,493,968 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.39% | 0.14% | 298,422 | 28,008 | 10.36% | 9,125,745 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.13% | 8,925 | -4,880 | -35.35% | 272,927 | Jun 30, 2024 |
The largest PTC Therapeutics shareholder by % of total assets is RTW INVESTMENTS, LP. The company owns 7.39M shares of PTC Therapeutics (PTCT), representing 3.50% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 1.03% | 0.00% | 791,164 | 311,143 | 64.82% | 24,193,795 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.68% | 0.17% | 522,895 | 250,000 | 91.61% | 15,990,129 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.90% | 0.01% | 686,525 | 219,865 | 47.11% | 20,993,935 | Jun 30, 2024 |
| BLACKROCK INC. | 10.16% | 0.01% | 7,772,140 | 207,054 | 2.74% | 237,672,042 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.10% | 2.68% | 6,962,227 | 198,227 | 2.93% | 212,904,902 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.27% | 0.01% | 208,302 | 180,561 | 650.88% | 6,369,875 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.42% | 0.00% | 317,579 | 175,289 | 123.19% | 9,711,566 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.23% | 0.01% | 179,679 | 157,460 | 708.67% | 5,494,584 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.77% | 0.04% | 1,357,638 | 131,890 | 10.76% | 41,516,570 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.34% | 0.00% | 1,787,780 | 124,712 | 7.50% | 54,681,341 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.16% | 0.01% | 122,890 | 122,890 | 100.00% | 3,757,976 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.42% | 0.02% | 318,173 | 121,522 | 61.80% | 9,729,730 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.63% | 0.10% | 478,441 | 121,139 | 33.90% | 14,630,726 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.24% | 0.22% | 1,715,791 | 109,950 | 6.85% | 52,468,889 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.12% | 0.01% | 94,800 | 94,800 | 100.00% | 2,898,984 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.12% | 0.39% | 94,318 | 94,318 | 100.00% | 2,884,244 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.12% | 0.21% | 90,000 | 90,000 | 100.00% | 2,752,200 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.11% | 0.00% | 85,147 | 73,484 | 630.06% | 2,603,795 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.20% | 0.00% | 152,402 | 73,305 | 92.68% | 4,660,454 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.09% | 0.01% | 68,020 | 68,020 | 100.00% | 2,080,000 | Jun 30, 2024 |
As of Jun 30 2024, PTC Therapeutics's largest institutional buyer is GOLDMAN SACHS GROUP INC. The company purchased 311.14K stocks of PTCT, valued at $24.19M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 3.59% | 0.00% | 2,749,340 | -1,360,452 | -33.10% | 84,074,817,000 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.10% | 0.00% | 78,599 | -1,356,881 | -94.52% | 2,403,557 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.39% | 0.02% | 300,000 | -970,000 | -76.38% | 9,174,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 10.73% | 0.04% | 8,208,606 | -692,959 | -7.78% | 251,019,171 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.90% | 0.05% | 2,981,559 | -688,257 | -18.75% | 91,147,762 | Jun 30, 2024 |
| FMR LLC | 1.44% | 0.00% | 1,104,099 | -622,963 | -36.07% | 33,763,347 | Jun 30, 2024 |
| MORGAN STANLEY | 1.98% | 0.00% | 1,516,757 | -546,284 | -26.48% | 46,382,445 | Jun 30, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 4.58% | 2.96% | 3,500,000 | -500,000 | -12.50% | 107,030,000 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.48% | 0.01% | 369,990 | -456,086 | -55.21% | 11,314,294 | Jun 30, 2024 |
| VANGUARD GROUP INC | 11.73% | 0.01% | 8,973,771 | -395,243 | -4.22% | 274,417,917 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.13% | 0.00% | 95,650 | -264,507 | -73.44% | 2,924,977 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.13% | 0.01% | 100,460 | -193,844 | -65.87% | 3,072,067 | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -167,048 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKETS CORP | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | - | - | - | -125,000 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -113,500 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.18% | 0.00% | 136,761 | -88,699 | -39.34% | 4,182,152 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.41% | 0.00% | 310,863 | -72,834 | -18.98% | 9,506,191 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.17% | 0.00% | 127,601 | -72,069 | -36.09% | 3,902,039 | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 0.07% | 0.01% | 53,093 | -46,661 | -46.78% | 1,623,584 | Jun 30, 2024 |
As of Jun 30 2024, PTC Therapeutics's biggest institutional seller is STATE STREET CORP. The company sold -1.36M shares of PTCT, valued at $84.07B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SQUAREPOINT OPS LLC | 0.16% | 0.01% | 122,890 | 122,890 | 100.00% | 3,757,976 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.12% | 0.01% | 94,800 | 94,800 | 100.00% | 2,898,984 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.12% | 0.21% | 90,000 | 90,000 | 100.00% | 2,752,200 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.09% | 0.01% | 68,020 | 68,020 | 100.00% | 2,080,000 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.01% | 59,818 | 59,818 | 100.00% | 1,829,234 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.08% | 0.00% | 59,698 | 59,698 | 100.00% | 1,840,995 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.08% | 0.15% | 57,812 | 57,812 | 100.00% | 1,767,891 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.07% | 0.00% | 54,982 | 54,982 | 100.00% | 1,979,352 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.07% | 0.01% | 54,569 | 54,569 | 100.00% | 1,668,720 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 40,974 | 40,974 | 100.00% | 1,252,985 | Jun 30, 2024 |
| NEO IVY CAPITAL MANAGEMENT | 0.05% | 0.24% | 40,708 | 40,708 | 100.00% | 1,245,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.08% | 30,971 | 30,971 | 100.00% | 947,093 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.04% | 0.01% | 27,661 | 27,661 | 100.00% | 845,872 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.02% | 0.18% | 19,000 | 19,000 | 100.00% | 581,020 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.02% | 0.01% | 18,665 | 18,665 | 100.00% | 570,776 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.02% | 0.06% | 17,328 | 17,328 | 100.00% | 530,000 | Jun 30, 2024 |
| NORGES BANK | 0.02% | 0.00% | 15,100 | 15,100 | 100.00% | 461,758 | Jun 30, 2024 |
| LGL PARTNERS, LLC | 0.02% | 0.05% | 12,000 | 12,000 | 100.00% | 366,960 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.01% | 0.07% | 10,971 | 10,971 | 100.00% | 335,493 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | 0.01% | 0.00% | 9,369 | 9,369 | 100.00% | 286,504 | Jun 30, 2024 |
| VITALSTONE FINANCIAL, LLC | 0.01% | 0.21% | 9,367 | 9,367 | 100.00% | 286,443 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.01% | 0.00% | 7,352 | 7,352 | 100.00% | 224,816 | Jun 30, 2024 |
| PEARL RIVER CAPITAL, LLC | 0.01% | 0.03% | 6,832 | 6,832 | 100.00% | 208,923 | Jun 30, 2024 |
| SANIBEL CAPTIVA TRUST COMPANY, INC. | 0.01% | 0.01% | 6,700 | 6,700 | 100.00% | 204,886 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.01% | 0.04% | 6,630 | 6,630 | 100.00% | 202,745 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.01% | 0.00% | 6,300 | 6,300 | 100.00% | 192,654 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.01% | 0.05% | 4,300 | 4,300 | 100.00% | 131,494 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.02% | 4,188 | 4,188 | 100.00% | 128,069 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.00% | - | 542 | 542 | 100.00% | 16,000 | Jun 30, 2024 |
| MANCHESTER CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 235 | 235 | 100.00% | 7,187 | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 0.00% | 0.00% | 170 | 170 | 100.00% | 5,199 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | 0.00% | - | 161 | 161 | 100.00% | 4,923 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 104 | 104 | 100.00% | 3,181 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 36 | 36 | 100.00% | 1,101 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | - | - | 30 | 30 | 100.00% | 917 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | 30 | 30 | 100.00% | 917 | Jun 30, 2024 |
| CVA FAMILY OFFICE, LLC | - | 0.00% | 17 | 17 | 100.00% | 520 | Jun 30, 2024 |
PTC Therapeutics's largest new institutional shareholder by number of shares is SQUAREPOINT OPS LLC, purchased 122.89K shares, valued at $3.76M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CANDRIAM S.C.A. | - | - | - | -167,048 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKETS CORP | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | - | - | - | -125,000 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -113,500 | -100.00% | - | Jun 30, 2024 |
| BURNEY CO/ | - | - | - | -42,040 | -100.00% | - | Jun 30, 2024 |
| EMPOWERED FUNDS, LLC | - | - | - | -41,598 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -35,510 | -100.00% | - | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | - | - | - | -33,852 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -31,438 | -100.00% | - | Jun 30, 2024 |
| GEORGE KAISER FAMILY FOUNDATION | - | - | - | -24,380 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -16,306 | -100.00% | - | Jun 30, 2024 |
| KNIGHTS OF COLUMBUS ASSET ADVISORS LLC | - | - | - | -15,693 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -13,908 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -12,753 | -100.00% | - | Jun 30, 2024 |
| INCEPTIONR LLC | - | - | - | -11,694 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -9,313 | -100.00% | - | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | - | - | - | -7,527 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -5,500 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,793 | -100.00% | - | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | - | - | - | -2,000 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -842 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -600 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -315 | -100.00% | - | Jun 30, 2024 |
| BYRNE ASSET MANAGEMENT LLC | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -14 | -100.00% | - | Jun 30, 2024 |
PTC Therapeutics's largest sold out institutional shareholder by shares sold is CANDRIAM S.C.A., sold -0.17M shares, valued at -, as of undefined.
PTC Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 1.33% | 4,725 | - | - | Feb 29, 2024 |
| Franklin Investors Securities Trust | 0.70% | 48,000,000 | - | - | Jan 31, 2024 |
| Franklin Investors Securities Trust | 0.70% | 48,000,000 | - | - | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.66% | 1,565,000 | - | - | Jan 31, 2024 |
| Vanguard Montgomery Funds | 0.57% | 136,453 | 23,068 | 20.34% | Mar 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.47% | 935,000 | - | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.40% | 815,000 | - | - | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.37% | 890,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.36% | 1,760,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.35% | 1,330,000 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.32% | 6,830,000 | - | - | Mar 28, 2024 |
| Virtus Equity & Convertible Income Fund | 0.27% | 530,000 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.25% | 5,225,000 | - | - | Mar 28, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.23% | 55,355 | - | - | Dec 31, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.19% | 178,985 | - | - | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.15% | 2,719,000 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.14% | 1,414,183 | 1,414,156 | 5237614.81% | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.14% | 456,100 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.10% | 51,936 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.10% | 18,784 | 5,703 | 43.60% | Mar 28, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.09% | 42,892 | - | - | Mar 31, 2024 |
| BUFFALO FUNDS | 0.09% | 600,000 | - | - | Mar 31, 2024 |
| BUFFALO FUNDS | 0.09% | 600,000 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.09% | 225,815 | - | - | Mar 31, 2024 |
| WANGER ADVISORS TRUST | 0.08% | 45,327 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.08% | 266,273 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.08% | 19,817 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.07% | 239,182 | - | - | Mar 31, 2024 |
| BNY MELLON VARIABLE INVESTMENT FUND | 0.07% | 17,937 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 366,019 | - | - | Mar 31, 2024 |
| ADVENT CONVERTIBLE & INCOME FUND | 0.07% | 248,000 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.07% | 3,124 | 3,124 | - | Feb 29, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.06% | 3,393,863 | 644,724 | 23.45% | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.06% | 480,611 | 184,747 | 62.44% | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.05% | 110,000 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.05% | 1,192 | 580 | 94.77% | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.05% | 598,923 | 265,540 | 79.65% | Jan 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.04% | 15,983 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.04% | 1,027,846 | 252,885 | 32.63% | Mar 31, 2024 |
| REYNOLDS FUNDS INC | 0.04% | 400 | - | - | Mar 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.03% | 20,200 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.03% | 105,729 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.02% | 21,262 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.02% | 159,256 | 79,332 | 99.26% | Aug 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.02% | 199,705 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.02% | 1,339,220 | - | - | Feb 29, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.02% | 152,917 | - | - | Mar 31, 2024 |
| RMB INVESTORS TRUST | 0.02% | 10,858 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 128,081 | - | - | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.02% | 10,510 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 29,856 | - | - | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.02% | 385,000 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,609 | -285 | -2.62% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 460,027 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 6,522,696 | -1,069,161 | -14.08% | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 138,075 | - | - | Jan 31, 2024 |
| Vericimetry Funds | 0.01% | 1,080 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.01% | 479,296 | -154,004 | -24.32% | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.01% | 3,223,000 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 670,511 | -295,600 | -30.60% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,011 | - | - | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.01% | 304,310 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 815,726 | - | - | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 7,038 | 5,938 | 539.82% | Dec 31, 2023 |
| FIDELITY FINANCIAL TRUST | 0.01% | 150,000 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 11,819 | 4,744 | 67.05% | Jan 31, 2024 |
| Harbor ETF Trust | 0.01% | 38,566 | 9,083 | 30.81% | Jan 31, 2024 |
| FIDELITY PURITAN TRUST | 0.01% | 420,235 | - | - | Jan 31, 2024 |
| BARON SELECT FUNDS | 0.01% | 80,392 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 12,501 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 39,332 | - | - | Mar 31, 2020 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.01% | 17,775 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 28,255 | 4,805 | 20.49% | Dec 31, 2023 |
| Calvert Responsible Index Series, Inc. | 0.01% | 10,263 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 19,583 | 310 | 1.61% | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.01% | 1,400,000 | - | - | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.01% | 100,000 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 229,220 | 5,829 | 2.61% | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 59,500 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 150,730 | - | - | Mar 31, 2024 |
| Cavanal Hill Funds | 0.00% | 9,832 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.00% | 10,548 | -7,816 | -42.56% | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 38,020 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 1,217,893 | -63,562 | -4.96% | Dec 31, 2023 |
| ALPS ETF Trust | 0.00% | 45,212 | - | - | Feb 29, 2024 |
| LORD ABBETT INVESTMENT TRUST | 0.00% | 3,345,000 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 715,542 | 23,862 | 3.45% | Feb 29, 2024 |
| CARILLON SERIES TRUST | 0.00% | 188,707 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 12,997 | -15,439 | -54.29% | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 276,472 | 110,209 | 66.29% | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 7,997 | - | - | Jan 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 346,916 | -27,150 | -7.26% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.00% | 725,000 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 6,854 | - | - | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 13,610 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.00% | 6,695 | -490 | -6.82% | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,459 | - | - | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 217,749 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 3,044 | 480 | 18.72% | Dec 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 133,433 | - | - | Mar 31, 2024 |
PTC Therapeutics's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 4.72K shares, compromising 1.33% of its total assets.
PTC Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 71 | -62.83% |
| 31 Mar, 24 | 191 | 6.11% |
| 31 Dec, 23 | 180 | -3.23% |
| 30 Sep, 23 | 186 | -11.85% |
| 30 Jun, 23 | 211 | -1.40% |
| 31 Mar, 23 | 214 | 0.94% |
| 31 Dec, 22 | 212 | -0.47% |
| 30 Sep, 22 | 213 | 14.52% |
| 30 Jun, 22 | 186 | 3.33% |
| 31 Mar, 22 | 180 | 1.69% |
| 31 Dec, 21 | 177 | -6.35% |
| 30 Sep, 21 | 189 | 0.53% |
| 30 Jun, 21 | 188 | -10.48% |
| 31 Mar, 21 | 210 | -3.23% |
| 31 Dec, 20 | 217 | 5.34% |
| 30 Sep, 20 | 206 | -5.07% |
| 30 Jun, 20 | 217 | 1.40% |
| 31 Mar, 20 | 214 | -6.14% |
| 31 Dec, 19 | 228 | 12.87% |
| 30 Sep, 19 | 202 | 5.76% |
| 30 Jun, 19 | 191 | - |
| 31 Mar, 19 | 191 | 6.11% |
| 31 Dec, 18 | 180 | -7.22% |
| 30 Sep, 18 | 194 | 3.74% |
| 30 Jun, 18 | 187 | 11.31% |
| 31 Mar, 18 | 168 | 18.31% |
| 31 Dec, 17 | 142 | -11.80% |
| 30 Sep, 17 | 161 | 23.85% |
| 30 Jun, 17 | 130 | -4.41% |
| 31 Mar, 17 | 136 | -2.16% |
| 31 Dec, 16 | 139 | 7.75% |
| 30 Sep, 16 | 129 | 4.03% |
| 30 Jun, 16 | 124 | -2.36% |
| 31 Mar, 16 | 127 | -23.49% |
| 31 Dec, 15 | 166 | -12.63% |
| 30 Sep, 15 | 190 | 6.74% |
| 30 Jun, 15 | 178 | 1.14% |
| 31 Mar, 15 | 176 | 29.41% |
| 31 Dec, 14 | 136 | 37.37% |
| 30 Sep, 14 | 99 | 17.86% |
| 30 Jun, 14 | 84 | 29.23% |
| 31 Mar, 14 | 65 | 6.56% |
| 31 Dec, 13 | 61 | - |
| 30 Sep, 13 | 61 | 1933.33% |
| 30 Jun, 13 | 3 | - |
As of 30 Jun 24, 71 institutions are holding PTC Therapeutics's shares, representing a decrease of -62.83% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 9,750,143 | -88.55% |
| 31 Mar, 24 | 85,134,817 | 0.70% |
| 31 Dec, 23 | 84,545,716 | 4.22% |
| 30 Sep, 23 | 81,125,682 | 0.46% |
| 30 Jun, 23 | 80,752,953 | 3.07% |
| 31 Mar, 23 | 78,349,290 | 2.08% |
| 31 Dec, 22 | 76,750,356 | 0.89% |
| 30 Sep, 22 | 76,075,352 | 2.68% |
| 30 Jun, 22 | 74,089,562 | -0.49% |
| 31 Mar, 22 | 74,456,113 | -1.17% |
| 31 Dec, 21 | 75,334,912 | 1.00% |
| 30 Sep, 21 | 74,589,110 | 0.64% |
| 30 Jun, 21 | 74,113,376 | 0.04% |
| 31 Mar, 21 | 74,080,715 | 1.29% |
| 31 Dec, 20 | 73,140,700 | 2.70% |
| 30 Sep, 20 | 71,214,960 | 3.83% |
| 30 Jun, 20 | 68,590,048 | 6.89% |
| 31 Mar, 20 | 64,170,467 | 5.13% |
| 31 Dec, 19 | 61,041,414 | -1.29% |
| 30 Sep, 19 | 61,836,615 | 6.08% |
| 30 Jun, 19 | 58,294,785 | -0.55% |
| 31 Mar, 19 | 58,617,627 | 20.19% |
| 31 Dec, 18 | 48,771,025 | 4.21% |
| 30 Sep, 18 | 46,800,795 | 8.57% |
| 30 Jun, 18 | 43,106,604 | 0.98% |
| 31 Mar, 18 | 42,686,359 | 12.06% |
| 31 Dec, 17 | 38,092,293 | 6.61% |
| 30 Sep, 17 | 35,730,830 | 6.58% |
| 30 Jun, 17 | 33,525,045 | 6.16% |
| 31 Mar, 17 | 31,579,908 | 10.12% |
| 31 Dec, 16 | 28,677,051 | -1.87% |
| 30 Sep, 16 | 29,224,182 | 2.29% |
| 30 Jun, 16 | 28,568,638 | -2.77% |
| 31 Mar, 16 | 29,382,884 | -19.08% |
| 31 Dec, 15 | 36,309,280 | 9.65% |
| 30 Sep, 15 | 33,112,471 | 1.54% |
| 30 Jun, 15 | 32,611,007 | 3.60% |
| 31 Mar, 15 | 31,476,427 | 10.98% |
| 31 Dec, 14 | 28,362,194 | 16.35% |
| 30 Sep, 14 | 24,376,838 | 6.10% |
| 30 Jun, 14 | 22,976,219 | 0.09% |
| 31 Mar, 14 | 22,954,712 | 50.35% |
| 31 Dec, 13 | 15,267,429 | 7.81% |
| 30 Sep, 13 | 14,161,627 | 6017.33% |
| 30 Jun, 13 | 231,500 | - |
PTC Therapeutics (PTCT) has 9.75M shares outstanding as of 30 Jun 24, down -88.55% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 12.75% | 0.10% |
| 31 Mar, 24 | 111.29% | 0.87% |
| 31 Dec, 23 | 112.97% | 0.98% |
| 30 Sep, 23 | 107.63% | 0.92% |
| 30 Jun, 23 | 108.06% | 0.96% |
| 31 Mar, 23 | 106.27% | 0.93% |
| 31 Dec, 22 | 107.00% | 0.94% |
| 30 Sep, 22 | 106.48% | 0.99% |
| 30 Jun, 22 | 103.81% | 0.95% |
| 31 Mar, 22 | 104.55% | 0.91% |
| 31 Dec, 21 | 106.91% | 0.96% |
| 30 Sep, 21 | 105.67% | 0.95% |
| 30 Jun, 21 | 105.25% | 0.94% |
| 31 Mar, 21 | 105.55% | 0.94% |
| 31 Dec, 20 | 106.18% | 0.96% |
| 30 Sep, 20 | 105.28% | 0.95% |
| 30 Jun, 20 | 105.28% | 1.00% |
| 31 Mar, 20 | 102.86% | 1.06% |
| 31 Dec, 19 | 98.37% | 0.82% |
| 30 Sep, 19 | 109.52% | 1.01% |
| 30 Jun, 19 | 104.26% | 0.95% |
| 31 Mar, 19 | 104.95% | 0.96% |
| 31 Dec, 18 | 104.71% | 1.11% |
| 30 Sep, 18 | 97.31% | 1.11% |
| 30 Jun, 18 | 93.43% | 0.89% |
| 31 Mar, 18 | 102.55% | 1.21% |
| 31 Dec, 17 | 92.13% | 1.23% |
| 30 Sep, 17 | 86.52% | 1.21% |
| 30 Jun, 17 | 84.61% | 1.00% |
| 31 Mar, 17 | 92.05% | 1.31% |
| 31 Dec, 16 | 83.93% | 1.14% |
| 30 Sep, 16 | 85.73% | 1.21% |
| 30 Jun, 16 | 84.02% | 1.12% |
| 31 Mar, 16 | 86.63% | 0.75% |
| 31 Dec, 15 | 107.14% | 1.12% |
| 30 Sep, 15 | 97.65% | 1.04% |
| 30 Jun, 15 | 97.05% | 1.07% |
| 31 Mar, 15 | 95.19% | 1.18% |
| 31 Dec, 14 | 89.85% | 1.30% |
| 30 Sep, 14 | 83.05% | 1.35% |
| 30 Jun, 14 | 78.33% | 0.89% |
| 31 Mar, 14 | 93.72% | 2.27% |
| 31 Dec, 13 | 64.23% | 1.81% |
| 30 Sep, 13 | 59.58% | 2237.83% |
| 30 Jun, 13 | 1.63% | - |
As of 30 Jun 24, PTC Therapeutics is held by 12.75% institutional shareholders, representing a 0.10% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 47 | -44.71% |
| 31 Mar, 24 | 85 | -13.27% |
| 31 Dec, 23 | 98 | -4.85% |
| 30 Sep, 23 | 103 | -11.97% |
| 30 Jun, 23 | 117 | 9.35% |
| 31 Mar, 23 | 107 | 3.88% |
| 31 Dec, 22 | 103 | -13.45% |
| 30 Sep, 22 | 119 | 50.63% |
| 30 Jun, 22 | 79 | -13.19% |
| 31 Mar, 22 | 91 | 21.33% |
| 31 Dec, 21 | 75 | -17.58% |
| 30 Sep, 21 | 91 | -9.90% |
| 30 Jun, 21 | 101 | 1.00% |
| 31 Mar, 21 | 100 | -7.41% |
| 31 Dec, 20 | 108 | 17.39% |
| 30 Sep, 20 | 92 | -22.03% |
| 30 Jun, 20 | 118 | 6.31% |
| 31 Mar, 20 | 111 | -11.90% |
| 31 Dec, 19 | 126 | 17.76% |
| 30 Sep, 19 | 107 | 12.63% |
| 30 Jun, 19 | 95 | -12.04% |
| 31 Mar, 19 | 108 | 21.35% |
| 31 Dec, 18 | 89 | 1.14% |
| 30 Sep, 18 | 88 | -14.56% |
| 30 Jun, 18 | 103 | 25.61% |
| 31 Mar, 18 | 82 | 24.24% |
| 31 Dec, 17 | 66 | -25.84% |
| 30 Sep, 17 | 89 | 67.92% |
| 30 Jun, 17 | 53 | -22.06% |
| 31 Mar, 17 | 68 | 9.68% |
| 31 Dec, 16 | 62 | - |
| 30 Sep, 16 | 62 | -1.59% |
| 30 Jun, 16 | 63 | -11.27% |
| 31 Mar, 16 | 71 | -17.44% |
| 31 Dec, 15 | 86 | -18.87% |
| 30 Sep, 15 | 106 | -10.17% |
| 30 Jun, 15 | 118 | 19.19% |
| 31 Mar, 15 | 99 | 2.06% |
| 31 Dec, 14 | 97 | 73.21% |
| 30 Sep, 14 | 56 | -11.11% |
| 30 Jun, 14 | 63 | 26.00% |
| 31 Mar, 14 | 50 | 19.05% |
| 31 Dec, 13 | 42 | -28.81% |
| 30 Sep, 13 | 59 | 1866.67% |
| 30 Jun, 13 | 3 | - |
47 institutional shareholders have increased their position in PTCT stock as of 30 Jun 24 compared to 85 in the previous quarter (a -44.71% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | -76.81% |
| 31 Mar, 24 | 69 | 23.21% |
| 31 Dec, 23 | 56 | -5.08% |
| 30 Sep, 23 | 59 | -4.84% |
| 30 Jun, 23 | 62 | -16.22% |
| 31 Mar, 23 | 74 | -5.13% |
| 31 Dec, 22 | 78 | 25.81% |
| 30 Sep, 22 | 62 | -16.22% |
| 30 Jun, 22 | 74 | 37.04% |
| 31 Mar, 22 | 54 | -15.63% |
| 31 Dec, 21 | 64 | 20.75% |
| 30 Sep, 21 | 53 | 6.00% |
| 30 Jun, 21 | 50 | -39.76% |
| 31 Mar, 21 | 83 | 5.06% |
| 31 Dec, 20 | 79 | 11.27% |
| 30 Sep, 20 | 71 | 22.41% |
| 30 Jun, 20 | 58 | -15.94% |
| 31 Mar, 20 | 69 | 15.00% |
| 31 Dec, 19 | 60 | 11.11% |
| 30 Sep, 19 | 54 | -5.26% |
| 30 Jun, 19 | 57 | 35.71% |
| 31 Mar, 19 | 42 | -16.00% |
| 31 Dec, 18 | 50 | -20.63% |
| 30 Sep, 18 | 63 | 40.00% |
| 30 Jun, 18 | 45 | -10.00% |
| 31 Mar, 18 | 50 | 16.28% |
| 31 Dec, 17 | 43 | 43.33% |
| 30 Sep, 17 | 30 | -28.57% |
| 30 Jun, 17 | 42 | 23.53% |
| 31 Mar, 17 | 34 | -32.00% |
| 31 Dec, 16 | 50 | 42.86% |
| 30 Sep, 16 | 35 | -2.78% |
| 30 Jun, 16 | 36 | -5.26% |
| 31 Mar, 16 | 38 | -25.49% |
| 31 Dec, 15 | 51 | 6.25% |
| 30 Sep, 15 | 48 | 54.84% |
| 30 Jun, 15 | 31 | -40.38% |
| 31 Mar, 15 | 52 | 126.09% |
| 31 Dec, 14 | 23 | -11.54% |
| 30 Sep, 14 | 26 | 116.67% |
| 30 Jun, 14 | 12 | 9.09% |
| 31 Mar, 14 | 11 | 10.00% |
| 31 Dec, 13 | 10 | 400.00% |
| 30 Sep, 13 | 2 | - |
| 30 Jun, 13 | - | - |
16 institutional shareholders have reduced their position in PTCT stock as of 30 Jun 24 compared to 69 in the previous quarter (a -76.81% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 71 | -62.83% | 9,750,143 | -88.55% | 12.75% | 0.10% | 47 | -44.71% | 16 | -76.81% |
| 31 Mar, 24 | 191 | 6.11% | 85,134,817 | 0.70% | 111.29% | 0.87% | 85 | -13.27% | 69 | 23.21% |
| 31 Dec, 23 | 180 | -3.23% | 84,545,716 | 4.22% | 112.97% | 0.98% | 98 | -4.85% | 56 | -5.08% |
| 30 Sep, 23 | 186 | -11.85% | 81,125,682 | 0.46% | 107.63% | 0.92% | 103 | -11.97% | 59 | -4.84% |
| 30 Jun, 23 | 211 | -1.40% | 80,752,953 | 3.07% | 108.06% | 0.96% | 117 | 9.35% | 62 | -16.22% |
| 31 Mar, 23 | 214 | 0.94% | 78,349,290 | 2.08% | 106.27% | 0.93% | 107 | 3.88% | 74 | -5.13% |
| 31 Dec, 22 | 212 | -0.47% | 76,750,356 | 0.89% | 107.00% | 0.94% | 103 | -13.45% | 78 | 25.81% |
| 30 Sep, 22 | 213 | 14.52% | 76,075,352 | 2.68% | 106.48% | 0.99% | 119 | 50.63% | 62 | -16.22% |
| 30 Jun, 22 | 186 | 3.33% | 74,089,562 | -0.49% | 103.81% | 0.95% | 79 | -13.19% | 74 | 37.04% |
| 31 Mar, 22 | 180 | 1.69% | 74,456,113 | -1.17% | 104.55% | 0.91% | 91 | 21.33% | 54 | -15.63% |
| 31 Dec, 21 | 177 | -6.35% | 75,334,912 | 1.00% | 106.91% | 0.96% | 75 | -17.58% | 64 | 20.75% |
| 30 Sep, 21 | 189 | 0.53% | 74,589,110 | 0.64% | 105.67% | 0.95% | 91 | -9.90% | 53 | 6.00% |
| 30 Jun, 21 | 188 | -10.48% | 74,113,376 | 0.04% | 105.25% | 0.94% | 101 | 1.00% | 50 | -39.76% |
| 31 Mar, 21 | 210 | -3.23% | 74,080,715 | 1.29% | 105.55% | 0.94% | 100 | -7.41% | 83 | 5.06% |
| 31 Dec, 20 | 217 | 5.34% | 73,140,700 | 2.70% | 106.18% | 0.96% | 108 | 17.39% | 79 | 11.27% |
| 30 Sep, 20 | 206 | -5.07% | 71,214,960 | 3.83% | 105.28% | 0.95% | 92 | -22.03% | 71 | 22.41% |
| 30 Jun, 20 | 217 | 1.40% | 68,590,048 | 6.89% | 105.28% | 1.00% | 118 | 6.31% | 58 | -15.94% |
| 31 Mar, 20 | 214 | -6.14% | 64,170,467 | 5.13% | 102.86% | 1.06% | 111 | -11.90% | 69 | 15.00% |
| 31 Dec, 19 | 228 | 12.87% | 61,041,414 | -1.29% | 98.37% | 0.82% | 126 | 17.76% | 60 | 11.11% |
| 30 Sep, 19 | 202 | 5.76% | 61,836,615 | 6.08% | 109.52% | 1.01% | 107 | 12.63% | 54 | -5.26% |
| 30 Jun, 19 | 191 | - | 58,294,785 | -0.55% | 104.26% | 0.95% | 95 | -12.04% | 57 | 35.71% |
| 31 Mar, 19 | 191 | 6.11% | 58,617,627 | 20.19% | 104.95% | 0.96% | 108 | 21.35% | 42 | -16.00% |
| 31 Dec, 18 | 180 | -7.22% | 48,771,025 | 4.21% | 104.71% | 1.11% | 89 | 1.14% | 50 | -20.63% |
| 30 Sep, 18 | 194 | 3.74% | 46,800,795 | 8.57% | 97.31% | 1.11% | 88 | -14.56% | 63 | 40.00% |
| 30 Jun, 18 | 187 | 11.31% | 43,106,604 | 0.98% | 93.43% | 0.89% | 103 | 25.61% | 45 | -10.00% |
| 31 Mar, 18 | 168 | 18.31% | 42,686,359 | 12.06% | 102.55% | 1.21% | 82 | 24.24% | 50 | 16.28% |
| 31 Dec, 17 | 142 | -11.80% | 38,092,293 | 6.61% | 92.13% | 1.23% | 66 | -25.84% | 43 | 43.33% |
| 30 Sep, 17 | 161 | 23.85% | 35,730,830 | 6.58% | 86.52% | 1.21% | 89 | 67.92% | 30 | -28.57% |
| 30 Jun, 17 | 130 | -4.41% | 33,525,045 | 6.16% | 84.61% | 1.00% | 53 | -22.06% | 42 | 23.53% |
| 31 Mar, 17 | 136 | -2.16% | 31,579,908 | 10.12% | 92.05% | 1.31% | 68 | 9.68% | 34 | -32.00% |
| 31 Dec, 16 | 139 | 7.75% | 28,677,051 | -1.87% | 83.93% | 1.14% | 62 | - | 50 | 42.86% |
| 30 Sep, 16 | 129 | 4.03% | 29,224,182 | 2.29% | 85.73% | 1.21% | 62 | -1.59% | 35 | -2.78% |
| 30 Jun, 16 | 124 | -2.36% | 28,568,638 | -2.77% | 84.02% | 1.12% | 63 | -11.27% | 36 | -5.26% |
| 31 Mar, 16 | 127 | -23.49% | 29,382,884 | -19.08% | 86.63% | 0.75% | 71 | -17.44% | 38 | -25.49% |
| 31 Dec, 15 | 166 | -12.63% | 36,309,280 | 9.65% | 107.14% | 1.12% | 86 | -18.87% | 51 | 6.25% |
| 30 Sep, 15 | 190 | 6.74% | 33,112,471 | 1.54% | 97.65% | 1.04% | 106 | -10.17% | 48 | 54.84% |
| 30 Jun, 15 | 178 | 1.14% | 32,611,007 | 3.60% | 97.05% | 1.07% | 118 | 19.19% | 31 | -40.38% |
| 31 Mar, 15 | 176 | 29.41% | 31,476,427 | 10.98% | 95.19% | 1.18% | 99 | 2.06% | 52 | 126.09% |
| 31 Dec, 14 | 136 | 37.37% | 28,362,194 | 16.35% | 89.85% | 1.30% | 97 | 73.21% | 23 | -11.54% |
| 30 Sep, 14 | 99 | 17.86% | 24,376,838 | 6.10% | 83.05% | 1.35% | 56 | -11.11% | 26 | 116.67% |
| 30 Jun, 14 | 84 | 29.23% | 22,976,219 | 0.09% | 78.33% | 0.89% | 63 | 26.00% | 12 | 9.09% |
| 31 Mar, 14 | 65 | 6.56% | 22,954,712 | 50.35% | 93.72% | 2.27% | 50 | 19.05% | 11 | 10.00% |
| 31 Dec, 13 | 61 | - | 15,267,429 | 7.81% | 64.23% | 1.81% | 42 | -28.81% | 10 | 400.00% |
| 30 Sep, 13 | 61 | 1933.33% | 14,161,627 | 6017.33% | 59.58% | 2237.83% | 59 | 1866.67% | 2 | - |
| 30 Jun, 13 | 3 | - | 231,500 | - | 1.63% | - | 3 | - | - | - |
PTC Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of PTC Therapeutics's stock was made by Gravier Pierre on Jul 18 2024, selling 2,269 shares at $34.02 per share (valued at $77.20K).
PTC Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | 1 | 8 | 12.50% |
| Q1 2024 | 42 | 23 | 182.61% |
| Q4 2023 | 2 | - | - |
| Q3 2023 | 4 | 4 | 100.00% |
| Q2 2023 | 18 | 44 | 40.91% |
| Q1 2023 | 40 | 57 | 70.18% |
| Q4 2022 | 4 | 5 | 80.00% |
| Q3 2022 | 2 | 4 | 50.00% |
| Q2 2022 | 3 | 9 | 33.33% |
| Q1 2022 | 40 | 34 | 117.65% |
| Q3 2021 | 10 | 21 | 47.62% |
| Q2 2021 | 7 | 5 | 140.00% |
| Q1 2021 | 53 | 67 | 79.10% |
| Q4 2020 | 43 | 117 | 36.75% |
| Q3 2020 | 5 | 30 | 16.67% |
| Q2 2020 | 11 | 29 | 37.93% |
| Q1 2020 | 41 | 30 | 136.67% |
| Q4 2019 | 10 | 21 | 47.62% |
| Q3 2019 | 11 | 22 | 50.00% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by PTC Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 6 | - |
| Q1 2024 | - | 22 | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | - | 2 | - |
| Q2 2023 | - | 27 | - |
| Q1 2023 | - | 52 | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | - | 7 | - |
| Q1 2022 | - | 31 | - |
| Q3 2021 | - | 10 | - |
| Q2 2021 | - | 5 | - |
| Q1 2021 | - | 47 | - |
| Q4 2020 | - | 73 | - |
| Q3 2020 | - | 24 | - |
| Q2 2020 | - | 12 | - |
| Q1 2020 | 1 | 24 | 4.17% |
| Q4 2019 | - | 10 | - |
| Q3 2019 | - | 10 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of PTC Therapeutics's stocks.
PTCT Ownership FAQ
Who Owns PTC Therapeutics?
PTC Therapeutics is owned by institutional shareholders (12.75%), insiders (2.35%), and public (84.91%). The largest institutional shareholder of PTC Therapeutics is VANGUARD GROUP INC (11.73% of total shares) and the top mutual fund owner is SPARROW FUNDS (1.33% of total shares).
Who are the major institutional shareholders of PTC Therapeutics?
PTC Therapeutics's major institutional shareholders are VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BLACKROCK INC., RTW INVESTMENTS, LP, and ARMISTICE CAPITAL, LLC. The top five shareholders own together 51.39% of the company's share outstanding.
How many PTC Therapeutics shareholders are there?
As of Jun 2024, there are 71 institutional shareholders of PTC Therapeutics.
What percentage of PTC Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 8.97M shares of PTC Therapeutics, representing 11.73% of the company's total shares outstanding, valued at $274.42M (as of Jun 2024).
What percentage of PTC Therapeutics is owned by WELLINGTON MANAGEMENT GROUP LLP?
As of Jun 2024, WELLINGTON MANAGEMENT GROUP LLP holds 8.21M shares of PTC Therapeutics (PTCT), compromising 10.73% of the company, valued at $251.02M.
What percentage of PTC Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of PTC Therapeutics. The company owns 7.77M of the company's shares outstanding (worth $237.67M).